Verrica Pharmaceuticals Inc. (VRCA)
Automate Your Wheel Strategy on VRCA
With Tiblio's Option Bot, you can configure your own wheel strategy including VRCA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol VRCA
- Rev/Share 0.0757
- Book/Share -0.1959
- PB -2.9739
- Debt/Equity -0.7873
- CurrentRatio 1.3428
- ROIC -2.1028
- MktCap 53876008.0
- FreeCF/Share -0.5661
- PFCF -1.0036
- PE -0.8371
- Debt/Assets 0.3467
- DivYield 0
- ROE 3.4829
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Verrica Pharmaceuticals (VRCA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Read More
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Noah L. Rosenberg, M.D., as Chief Medical Officer.
Read More
About Verrica Pharmaceuticals Inc. (VRCA)
- IPO Date 2018-06-15
- Website https://www.verrica.com
- Industry Biotechnology
- CEO Jayson M. Rieger
- Employees 71